News

Kowa Pharmaceuticals America, a specialty pharmaceutical company, has plans to divest its franchise of diclofenac products, including PRO-513 for the treatment of acute migraine headache pain and PRO-571

PPG Industries, a manufacturer of chemical products, reports a net loss of $111m in the first quarter, compared to a net loss of $100m for the same period

Industry, nonprofit and government experts shared their insights on a variety of topics, including the future of chemicals management and TSCA reform, coping with the latest Global Harmonization

Genomic Health, a life science company, has reported that the Quasar validation study met its primary endpoint to predict the likelihood of recurrence for stage II colon cancer

According to the agreed-upon terms, Nippon Kayaku will be responsible for regulatory strategy and seeking to obtain requisite product registrations, including performing any clinical studies that may be

Johnson & Johnson, LLC operates in Russia, Ukraine and CIS countries and is one of the subsidiaries of Johnson & Johnson. Johnson & Johnson LLC will have exclusive

The appointment reflects Alnara’s growing operations as the company prepares to submit a new drug application and commercialize liprotamase, a novel, oral, porcine-free pancreatic enzyme replacement therapy that

Under the new agreement, Aetna members whose plans do not require referrals will be able to receive covered services, at in-network rates from Mayo Clinic Florida and its

The four-year, sole-source base contract is valued at approximately $4.9 million. Cangene expects to deliver the product during fiscal 2010. The US Department of Defense (DoD) has two